Ann: Appendix 4C & Company Update - Sep 2018, page-25

Hi Lastly
Palatability was my main concern also, although I understood the micronisation would deliver more MPL across the blood barrier but to have the dose down to 1 single pill is Brilliant.
The Olivia Newton John Foundations additional validation of MPL having a Positive effect in fighting 27 of 30 cancers as independent research that backs up PAA's original clinical data.
I also am thinking exactly the same when it comes to Elanco,, they won't waste a minute to take this off PAA's hands let alone use the whole 6 months they have to exercise the Agreement. "world wide manufacture and distribution" thats a Blue Chip agreement....
Sure we have to wait for the Science now, Phase II primary endpoint met and this is a Home Run...